f-11

Pseudoginsenoside F11 (Ginsenoside A1) 从人参根和叶中分离得到。PF11在一系列心血管和中枢神经系统疾病中具有广泛的保护作用。

DF-1111301 是一种具有抗组胺 H1和抗PAF活性的新型抗过敏化合物。

IDF-11774 是新型低氧诱导因子 α (HIFα)-1的抑制剂，其 IC50=3.65 μM。。

GDCNF-11, 一种HIM-PROTACGPX4降解剂，依赖于HSP90伴侣复合物的作用，促使GPX4发生泛素化并加速其降解。此作用能够有效降低GPX4的内源性水平，进而在HT-1080细胞中诱导铁死亡(ferroptosis)。其DC50值达到0.08 μM。

PF-1163B is an antifungal agent form Penicillium sp. II. PF-1163B inhibits ergosterol (ERG) synthesis with IC50 value of 34 ng ml. PF-1163B showed potent growth inhibitory activity against pathogenic fungal strain Candida albicans but did not show cytotox

PF-1185A is a bio-active chemical.

VUF-11222 是 CXCR3 非拟肽激动剂，可诱导胶质堆积。VUF 11222 可用于研究视网膜炎症。

STF-118804是一种烟酰胺磷酸核糖基转移酶 Nampt 高选择性抑制剂，降低大多数 B-ALL 细胞系的活力，IC50 <10 nM。

GXF-111是一种PROTAC分子，能够选择性促进BRD3与BRD4-L在细胞内的降解。该分子与BRD3BD1和BRD3BD2的结合亲和力显著，Ki值分别为11.97 nM和2.35 nM。GXF-111主要用于癌症研究领域。

PF-1163A, a depsipeptide antifungal compound isolated from Penicillium, blocks ergosterol synthesis with an IC50 of 12 ng/ml. This compound specifically inhibits the enzyme ERG25p, a C-4 methyl oxidase in the ergosterol biosynthetic pathway, leading to its antifungal activity. Notably, in Saccharomyces cerevisiae modified to express ERG biosynthesis genes, PF-1163A exhibits an inhibition concentration (MIC value) of 12.5 µg/ml against ERG25p, though strains overexpressing ERG25p show resistance. Additionally, PF-1163A effectively suppresses the growth of Candida albicans (MIC = 8 µg/ml), without affecting other Candida species, Aspergillus fumigatus, or HepG2 cells. Remarkably, it enhances the efficacy of fluconazole against azole-resistant C. albicans strains, showing a significant decrease in MICs (1 and 0.0078 µg/ml alone and in combination, respectively). PF-1163A distinguishes itself from PF-1163B by its more polar nature.

LY294002 (SF 1101) 是一种 PI3K 的广谱抑制剂，抑制 PI3Kα、PI3Kδ 和 PI3Kβ (IC50=0.5 0.57 0.97 μM)。LY294002 也是 DNA-PK 抑制剂 (IC50=1.4 μM) 和 CK2 抑制剂 (IC50=98 nM)。LY294002 可以激活凋亡和自噬。

Nintedanib (Intedanib) 是一种三重血管激酶抑制剂，抑制 VEGFR1、VEGFR2、VEGFR3 (IC50=34 13 13 nM)，FGFR1、FGFR2、FGFR3 (IC50=69 37 108 nM)，PDGFRα、PDGFRβ (IC50=59 65 nM)。Nintedanib 具有抗肿瘤活性，通过抑制血管生成来抑制肿瘤生长。

VUF11207 fumarate 是一种 CXCR7激动剂和高效CXCR7配体，pKi 为 8.1。它可诱导CXCR7的β-arrestin2募集和随后的内在化，pEC50分别为 8.8 和 7.9。

SF 11是一种有效的脑渗透神经肽 Y Y2 受体拮抗剂 (IC50=199 nM)。具有抗抑郁药样活性。

Monastrol ((±)-Monastrol) 是一种具有高效性和细胞渗透性的有丝分裂驱动蛋白Eg5的抑制剂，IC50值为 14 μM。

F 11334A1 是一种天然化合物，可作为天然产物对照品，其 CAS 号为 171812-79-6。

JH-VIII-157-02 是一种 ALK 抑制剂，可抑制棘皮动物微管相关蛋白样 4-ALK (EML4-ALK)，对EML4-ALK G1202R、EML4-ALKwt、EML4-ALK C1156Y、EML4-ALK F1174L 和 EML4-ALK F1174L 的 IC50 均为 2 nM。

SF1126 is a relevant pan and dual first-in-class PI3K BRD4 inhibitor. SF1126 is an RGDS-conjugated LY294002 prodrug, which is designed to exhibit increased solubility and bind to specific integrins within the tumor compartment.

Toxoflavin (Xanthothricin) 是一种 TCF4 β-catenin 复合物抑制剂，也是一种 KDM4A 抑制剂，有抗肿瘤和抗菌作用。

Fructo-oligosaccharide DP12 GF11 is a member of fructooligosaccharides (FOS) characterized by a degree of polymerization (DP) of 12. FOS compounds consist of 11 fructose units connected by (2→1)-β-glycosidic bonds, with a lone D-glucosyl unit located at the non-reducing end.

VUF11418是一种针对CXCR3的选择性非肽模拟激动剂。

DCAF11 ligand 1 是一种与 E3 连接酶 DCAF11 结合的配体，用于合成 PROTAC 降解剂 FF2039。

ACKR3 (CXCR7) chemokine receptor agonist

VUF11211 is an effective antagonist of CXCR3 that acts by extending from the minor pocket into the major pocket of the transmembrane domains.